Epidemiology of tuberculosis in the United States

Clinics in Chest Medicine

Volumn 26, Issue 2, 2005, Pages 183-195

  Schneider, Eileen ^a   Moore, Marisa ^a,b   Castro, Kenneth G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA COOPERATIVE EXTENSION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ISONIAZID; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFAMPICIN; RIFAPENTINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STREPTOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHEMOTHERAPY; DATA BASE; DISEASE TRANSMISSION; EPIDEMIC; ETHNOLOGY; GOVERNMENT; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RATE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; REVIEW; SOCIOECONOMICS; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

EID: 17044383380     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.02.007     Document Type: Review

References (96)

1. A.M. Lowell Tuberculosis morbidity and mortality and its control A.M. Lowell L.B. Edwards C.E. Palmer Tuberculosis 1969 Harvard University Press Cambridge (MA) 1 65
2. P.P. Jacobs The control of tuberculosis in the United States 1940 National Tuberculosis Association New York 1 387
3. S.M. Blower, A.R. McLean, and T.C. Porco The intrinsic transmission dynamics of tuberculosis epidemics Nat Med 1 8 1995 815 821
4. R.G. Paterson The evolution of official tuberculosis control in the United States Public Health Rep 62 10 1947 336 341
5. R.H. Shryock National Tuberculosis Association, 1904-1954 1957 National Tuberculosis Association New York 1 342
6. E.R. Long, and F.D. Hopkins History of diagnostic standards and classification of tuberculosis of the National Tuberculosis Association Am Rev Tuberc 65 4 1952 494 504
7. C. Northrop, R.J. Anderson, and H.I. Sauer What is a reportable case of tuberculosis? Public Health Rep 64 31 1949 961 968
8. United States Public Health Service What is a reportable case of tuberculosis? Public Health Rep 66 40 1951 1291 1294
9. Centers for Disease Control and Prevention Case definitions for infectious conditions under public health surveillance MMWR Morb Mortal Wkly Rep 46 RR-10 1997 40 41
10. Centers for Disease Control and Prevention Reported tuberculosis in the United States, 2003 2004 US Department of Health and Human Services Atlanta (GA)
11. Centers for Disease Control and Prevention Tuberculosis control laws-United States, 1993 MMWR Morb Mortal Wkly Rep 42 RR-15 1993 1 28
12. The Arden House Conference on Tuberculosis. Washington, DC; 1960. US Department of Health, Education, and Welfare, Public Health Service Publication No. 784, p. 1-68
13. L.B. Reichman The U-shaped curve of concern Am Rev Respir Dis 144 1991 741 742
14. R.E. Brown, B. Miller, and W.R. Taylor Health-care expenditures for tuberculosis in the United States Arch Intern Med 155 1995 1595 1600
15. Centers for Disease Control and Prevention A strategic plan for the elimination of tuberculosis in the United States MMWR Morb Mortal Wkly Rep 38 S-3 1989 1 25
16. M.F. Cantwell, D.E. Snider, and G.M. Cauthen Epidemiology of tuberculosis in the United States, 1985 through 1992 JAMA 272 7 1994 535 539
17. K. Brudney, and J. Dobkin Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs Am Rev Respir Dis 144 1991 745 749
18. D.E. Snider, and W.L. Roper The new tuberculosis JAMA 326 10 1992 703 705
19. M.T. McKenna, E. McCray, and I. Onorato The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993 N Engl J Med 332 1995 1071 1076
20. C. Beck-Sague, S.W. Dooley, and M.D. Hutton Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections JAMA 268 10 1992 1280 1286
21. Centers for Disease Control and Prevention Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991 MMWR Morb Mortal Wkly Rep 40 34 1991 585 591
22. B.R. Edlin, J.I. Tokars, and M.H. Grieco An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome N Engl J Med 326 1992 1514 1521
23. T.R. Frieden, T. Sterling, and A. Pablos-Mendez The emergence of drug-resistant tuberculosis in New York City N Engl J Med 328 1993 521 526
24. S.W. Dooley, M.E. Villarino, and M. Lawrence Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients JAMA 267 1992 2632 2635
25. J.A. Jereb, M. Klevens, and T.D. Privett Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis Arch Intern Med 155 1995 854 859
26. M.L. Pearson, J.A. Jereb, and T.R. Frieden Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis Ann Intern Med 117 1992 191 196
27. C.L. Daley, P.M. Small, and G.F. Schecter An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus N Engl J Med 326 1992 231 235
28. S.E. Valway, R.B. Greifinger, and M. Papania Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991 J Infec Dis 170 1994 151 156
29. Centers for Disease Control and Prevention Drug-resistant tuberculosis among the homeless-Boston MMWR Morb Mortal Wkly Rep 34 28 1985 429 431
30. Centers for Disease Control and Prevention. Tuberculosis among residents of shelters for the homeless-Ohio, 1990. MMWR Morb Mortal Wkly Rep 1991;40(50):869-71, 877
31. Centers for Disease Control and Prevention National action plan to combat multidrug-resistant tuberculosis MMWR Morb Mortal Wkly Rep 41 RR-11 1992 1 30
32. T.R. Frieden, P.I. Fujiwara, and R.M. Washko Tuberculosis in New York City- turning the tide N Engl J Med 333 1995 229 233
33. M.T. McKenna, E. McCray, and J.L. Jones The fall after the rise: tuberculosis in the United States, 1991 through 1994 Am J Pub Health 88 1998 1059 1063
34. P.I. Fujiwara Tide pools: what will be left after the tide has turned? Int J Tuberc Lung Dis 4 12 2000 S111 S116
35. Centers for Disease Control and Prevention Progressing toward tuberculosis elimination in low-incidence areas of the United States MMWR Morb Mortal Wkly Rep 51 RR-5 2002 1 14
36. Centers for Disease Control and Prevention Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment MMWR Morb Mortal Wkly Rep 48 RR-9 1999 1 13
37. Centers for Disease Control and Prevention Federal tuberculosis task force plan in response to the Institute of Medicine report, ending neglect: the elimination of tuberculosis in the United States 2003 Centers for Disease Control and Prevention, US Department of Health and Human Services Atlanta (GA) 1 76
38. L.J. Nelson, E. Schneider, and C.D. Wells Epidemiology of childhood tuberculosis in the United States, 1993-2001: the need for continued vigilance Pediatrics 114 2004 333 341
39. Centers for Disease Control and Prevention Racial disparities in tuberculosis-selected southeastern states, 1991-2002 MMWR Morb Mortal Wkly Rep 53 25 2004 556 559
40. E.A. Talbot, M. Moore, and E. McCray Tuberculosis among foreign-born persons in the United States, 1993-1998 JAMA 284 2000 2894 2900
41. P.L. Zuber, M.T. McKenna, and N.J. Binkin Long-term risk of tuberculosis among foreign-born persons in the United States JAMA 278 1997 304 307
42. C.D. Wells, P.L. Zuber, and C.M. Nolan Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington Am J Respir Crit Care Med 156 2 1997 573 577
43. Centers for Disease Control and Prevention Division of Global Migration and Quarantine. Technical instructions for panel physicians Available at: http://www.cdc.gov/ncidod/dq/panel.htm Accessed August 5, 2004
44. World Health Organization TB-a global emergency. WHO TB programme WHO/TB/94.177 1994 World Health Organization Geneva (Switzerland) 1 28
45. C. Dye, S. Scheele, P. Dolin for the WHO Global Surveillance and Monitoring Project Global burden of tuberculosis JAMA 282 1999 677 686
46. World Health Organization Global tuberculosis control: surveillance, planning, financing. WHO report WHO/HTM/TB2004.331 2004 World Health Organization Geneva (Switzerland)
47. Laserson K.F., Yen N.T.N., Thornton C., et al. Improvement in acid-fast bacilli sputum smear sensitivity following processing with C18- carboxypropylbetaine: a study in US-bound immigrants from Viet Nam. J Clin Microbiol, in press
48. Centers for Disease Control and Prevention Preventing and controlling tuberculosis along the US-Mexico border MMWR Morb Mortal Wkly Rep 50 RR-1 2002 1 28
49. E. Schneider, K.F. Laserson, and C.D. Wells Tuberculosis along the United States-Mexico border, 1993-2001 Rev Panam Salud Publica 16 1 2004 23 34
50. C.D. Wells, and L.J. Nelson New international efforts in childhood tuberculosis: proceedings from the 2002 workshop on childhood tuberculosis, Montreal, Canada, 6-7 October 2002 Int J Tuberc Lung Dis 8 5 2004 630 635
51. L.J. Nelson, and C.D. Wells Global epidemiology of childhood tuberculosis Int J Tuberc Lung Dis 8 5 2004 636 647
52. P. Spradling, and R. Ridzon Multidrug-resistant tuberculosis (MDR TB) I.W. Fong K. Drlica Reemergence of established pathogens in the 21st century 2003 Kluwer Academic/Plenum Publishers New York 245 293
53. S.S. Rajbhandary, S.M. Marks, and N.N. Bock Costs of patients hospitalized for multidrug-resistant tuberculosis Int J Tuberc Lung Dis 8 8 2004 1012 1016
54. A.B. Bloch, P.M. Simone, and E. McCray Preventing multidrug-resistant tuberculosis JAMA 275 6 1996 487 489
55. A.B. Bloch, G.M. Cauthen, and I.M. Onorato Nationwide survey of drug-resistant tuberculosis in the United States JAMA 271 9 1994 665 671
56. M. Moore, I.M. Onorato, and E. McCray Trends in drug-resistant tuberculosis in the United States, 1993-1996 JAMA 278 10 1997 833 837
57. T.R. Frieden, L. Fine Sherman, and K. Lay Maw A multi-institutional outbreak of highly drug-resistant tuberculosis JAMA 276 15 1996 1229 1235
58. T. Agerton, S. Valway, and B. Gore Transmission of a highly drug-resistant strain (Strain W1) of Mycobacterium tuberculosis JAMA 278 13 1997 1073 1077
59. T.B. Agerton, S.E. Valway, and R.J. Blinkhorn Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States Clin Infect Dis 29 1999 85 92
60. C. Dye, M.A. Espinal, and C.J. Watt Worldwide incidence of multidrug-resistant tuberculosis J Infec Dis 185 2002 1197 1202
61. World Health Organization Anti-tuberculosis drug resistance in the world, Report No. 3 2004 World Health Organization Geneva (Switzerland) 1 92
62. Centers for Disease Control and Prevention Missed opportunities for prevention of tuberculosis among persons with HIV infection-selected locations, United States, 1996-1997 MMWR Morb Mortal Wkly Rep 49 30 2000 685 687
63. Centers for Disease Control and Prevention Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens MMWR Morb Mortal Wkly Rep 51 10 2002 214 215
64. American Thoracic Society Centers for Disease Control and Prevention, Infectious Diseases Society of America. ATS/CDC/IDSA Statement on the treatment of tuberculosis Am J Respir Crit Care Med 167 2003 603 662
65. Centers for Disease Control and Prevention Guidelines for preventing opportunistic infections among HIV-infected persons-2002 MMWR Morb Mortal Wkly Rep 51 RR-8 2002 1 52
66. Centers for Disease Control and Prevention Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors MMWR 49 9 2000 185 189
67. Centers for Disease Control and Prevention Guidelines updated January 20, 2004. Updated guidelines for the use of rifamycins for the treatment of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors Available at: http://www.cdc.gov/nchstp/tb/TB_HIV_Drugs/TOC.htm Accessed September 1, 2004
68. Centers for Disease Control and Prevention Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations MMWR Morb Mortal Wkly Rep 47 RR-20 1998 1 58
69. M. Moore, E. McCray, and I.M. Onorato Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994 Public Health Rep 114 1999 269 277
70. R.W. Shafer, S.P. Singh, C. Larkin, and P.M. Small Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent person Tuber Lung Dis 76 1995 575 577
71. Centers for Disease Control and Prevention Drug-susceptible tuberculosis outbreak in a state correctional facility housing HIV-infected inmates- South Carolina, 1999-2000 MMWR Morb Mortal Wkly Rep 49 46 2000 1041 1044
72. Centers for Disease Control and Prevention Tuberculosis outbreaks in prison housing units for HIV-infected inmates-California, 1995-1996 MMWR Morb Mortal Wkly Rep 48 4 1999 79 82
73. P. Spradling, D. Drociuk, and S. McLaughlin Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak Clin Infect Dis 35 2002 1106 1112
74. P.D. McElroy, K.L. Southwick, and E.R. Fortenberry Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus Clin Infect Dis 36 2003 1305 1312
75. A. Vernon, W. Burman, D. Benator for the TB Trials Consortium Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid Lancet 353 1999 1843 1847
76. L. Sandman, N.W. Schluger, and A.L. Davidow Risk factors for rifampin-monoresistant tuberculosis Am J Respir Crit Care Med 159 1999 468 472
77. E.L. Corbett, C.J. Watt, and N. Walker The growing burden of tuberculosis Arch Intern Med 163 2003 1009 1021
78. E.L. Corbett, R. Steketee, and F.O. ter Kuile HIV-1/AIDS and the control of other infectious diseases in Africa Lancet 359 2002 2177 2187
79. Joint United Nations Programme on HIV/AIDS 2004 Report on the global AIDS epidemic. UNAIDS/04.16E 2004 UNAIDS Geneva (Switzerland)
80. R. Gupta, A. Irwin, and M.C. Ravigilone Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis Lancet 363 2004 320 324
81. American Thoracic Society Board of Directors Rapid diagnostic tests for tuberculosis Am J Respir Crit Care Med 155 1997 1804 1814
82. G.H. Mazurek, P.A. LoBue, and C.L. Daley Comparison of a whole-blood interferon-gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection JAMA 286 14 2001 1740 1747
83. Centers for Disease Control and Prevention Guidelines for using QuantiFERON®-TB Test for diagnosing latent Mycobacterium tuberculosis infection MMWR Morb Mortal Wkly Rep 52 RR-2 2003 15 18
84. A. Lalvani, A.A. Pathan, and H. McShane Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Am J Respir Crit Care Med 163 2001 824 828
85. P.F. Barnes, and M.D. Cave Molecular epidemiology of tuberculosis N Engl J Med 349 12 2003 1149 1156
86. G.L. Woods The mycobacteriology laboratory and new diagnostic techniques Infect Dis Clin North Am 16 1 2002 127 145
87. K.G. Castro, and H.W. Jaffe Rationale and methods for the national tuberculosis genotyping and surveillance network Emerg Infect Dis 8 11 2002 1188 1191
88. J.T. Crawford, C.R. Braden, and B.A. Schable National tuberculosis genotyping and surveillance network: design and methods Emerg Infect Dis 8 11 2002 1192 1196
89. P.M. Small, P.C. Hopewell, and S.P. Singh The epidemiology of tuberculosis in San Francisco N Engl J Med 330 24 1994 1703 1709
90. P.M. Small, N.B. McClenny, and S.P. Singh Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures J Clin Microbiol 31 7 1993 1677 1682
91. C.R. Braden, G.L. Templeton, and W.W. Stead Retrospective detection of laboratory cross-contamination of Mycobacterium tuberculosis cultures with use of DNA fingerprint analysis Clin Infec Dis 24 1997 35 40
92. L.S. Rosenblum, T.R. Navin, and J.T. Crawford Molecular epidemiology of tuberculosis N Engl J Med 349 24 2003 2364
93. The TB Trials Consortium Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial Lancet 360 2002 528 534
94. Centers for Disease Control and Prevention Development of new vaccines for tuberculosis MMWR Morb Mortal Wkly Rep 47 RR-13 1998 1 6
95. S.G. Reed, M.R. Alderson, and W. Dalemans Prospects for a better vaccine against tuberculosis Tuberculosis 83 2003 213 219
96. National Coalition for Elimination of Tuberculosis Tuberculosis elimination: the federal funding gap 2004 National Coalition for Elimination of Tuberculosis 1 19